Fenofibrate is not a statin. It belongs to a completely different class of cholesterol-lowering drugs called fibrates. While both fenofibrate and statins are prescribed to improve cholesterol and blood fat levels, they work through different biological mechanisms, target different parts of your lipid profile, and are often used for different reasons.
How Fenofibrate Differs From Statins
Statins lower cholesterol by blocking an enzyme in the liver that your body needs to produce cholesterol. This makes them especially effective at reducing LDL (“bad”) cholesterol. Common statins include atorvastatin (Lipitor), rosuvastatin (Crestor), and simvastatin (Zocor).
Fenofibrate works through an entirely different pathway. It activates a protein called PPARα, which acts like a switch that turns on genes involved in fat metabolism. When this switch is flipped, your body breaks down more triglycerides and clears fat-rich particles from your bloodstream more efficiently. The result is a sharp drop in triglycerides, the most common type of fat in your blood.
The practical difference shows up clearly in lab results. In a head-to-head comparison of fenofibrate (200 mg) and atorvastatin (10 mg) in patients with type 2 diabetes, fenofibrate reduced triglycerides by 42% but lowered LDL cholesterol by only 7%. Atorvastatin cut LDL by 28% but reduced triglycerides by just 11%. Each drug has a clear strength: statins are the go-to for high LDL, while fenofibrate is primarily prescribed for high triglycerides.
When Fenofibrate Is Prescribed
The official indication for fenofibrate is hypertriglyceridemia, meaning triglyceride levels high enough to pose a health risk. Very high triglycerides (typically above 500 mg/dL) can trigger pancreatitis, a painful and potentially dangerous inflammation of the pancreas. Fenofibrate is one of the most effective tools for bringing those numbers down quickly.
It’s also prescribed for mixed dyslipidemia, where both triglycerides and cholesterol are elevated. In these cases, your doctor may use fenofibrate alongside a statin rather than instead of one.
Taking Fenofibrate With a Statin
Because fenofibrate and statins target different problems, they’re sometimes prescribed together, particularly for people with diabetes or metabolic syndrome who have both high LDL and high triglycerides. This combination is generally considered safe, though it does carry a slightly higher risk of muscle-related side effects than either drug alone.
The risk of serious muscle injury (rhabdomyolysis) with fenofibrate plus a statin is very low. A review of FDA adverse event data found that the rate of rhabdomyolysis with fenofibrate combined with statins was approximately 0.58 cases per million prescriptions. For context, the older fibrate gemfibrozil combined with statins carried a rate roughly 15 times higher. That’s why fenofibrate is the preferred fibrate when combination therapy is needed. A joint advisory from the American College of Cardiology, American Heart Association, and National Heart, Lung, and Blood Institute reviewed eight clinical trials of statin-fibrate therapy and concluded that the combination “appears to have a relatively low incidence of myopathy, especially when used in persons without multiple-system disease or multiple medications.”
Risk factors that can increase the chance of muscle problems include older age, kidney or liver disease, hypothyroidism, and taking multiple medications. If you’re on both drugs, unexplained muscle pain or weakness is worth reporting to your doctor promptly.
Dosage and Forms
Fenofibrate is taken once daily by mouth, with or without food. It’s sold under several brand names, including TriCor, Antara, Lofibra, and Triglide, and is widely available as a generic. Tablet strengths range from 40 mg to 160 mg, and capsule strengths range from 30 mg to 200 mg. The typical dose for high triglycerides is 54 to 160 mg daily (tablet form), while mixed dyslipidemia is usually treated at 160 mg daily.
One important detail: different fenofibrate formulations are not interchangeable. A 160 mg tablet from one manufacturer may not deliver the same amount of active drug as a 200 mg capsule from another. If your pharmacy switches your brand or formulation, it’s worth confirming the change with your prescriber.
Kidney Function and Fenofibrate
Unlike most statins, fenofibrate requires dose adjustment based on kidney function. Guidelines vary by country, but in the United States, a dose reduction is recommended when creatinine clearance drops below 80 mL/min. For moderate kidney impairment, starting doses are typically reduced to 40 to 54 mg daily. People with severe kidney disease (an estimated GFR below 30) are generally not candidates for fenofibrate at all. Your doctor will check kidney function before starting the medication and periodically afterward.